Implanting a pouch of stem-cell-derived pancreas cells under the skin of type 1 diabetics has enabled them to live without ...

The latest clinical trial results from Eli Lilly show the drug manufacturer's once-weekly insulin injection is just as ...

For people with type 1 diabetes, management burden including suboptimal insulin preparations remains a major barrier to ...

A new study highlights promising results for a once-weekly insulin injection in managing blood sugar levels for people with ...

Clinical trials of a new, once-a-week insulin have shown that it controls blood sugar as well as daily injections of an ...

Eli Lilly’s experimental insulin that is injected just once a week is as effective as daily insulin injections for ...

Weekly insulin shots can help control both Type 1 and Type 2 diabetes as well as daily injections do, a pair of clinical ...

The late-stage clinical trial results showed that Eli Lilly’s once-weekly insulin efsitora matched daily injections for ...

Eli Lilly and Company (NYSE: LLY) today announced detailed results from the QWINT-5 phase 3 trial evaluating once-weekly ...

People with type 1 or type 2 diabetes could soon benefit from weekly insulin injections after new research showed they are as effective at controlling blood sugar levels as daily jabs of long-acting ...

New research published in New England Journal of Medicine and presented at this year's Annual Meeting of the European ...

New research published in NEJM and presented at this year’s Annual Meeting of the European Association for the Study of Diabetes (EASD) in Madrid (9-13 Sept) shows that a new class of insulin that is ...